Valuation: H&R GmbH & Co. KGaA

Market Cap 275M 313M 261M 236M 444M 29.99B 450M 3.12B 1.2B 15.33B 1.17B 1.15B 49.15B P/E 2026 *
5.73x
P/E 2027 * 20.1x
Enterprise Value 298M 339M 283M 255M 481M 32.48B 487M 3.38B 1.3B 16.6B 1.27B 1.24B 53.24B EV / Sales 2026 *
0.21x
EV / Sales 2027 * 0.21x
Free-Float
21.97%
Yield 2026 *
0.68%
Yield 2027 * 0.68%
08-15 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-15 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-01 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2025 CI
01-28 Kepler Cheuvreux Favors BASF and Bayer, Avoids H&R and Evonik DP
11-15 H&R GmbH & Co. KGaA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
11-14 H&R GmbH & Co. KGaA Revises Earnings Guidance for the Full Year 2025 CI
25/08/25 Nils Hansen acquired additional 7.78% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?15 million. CI
15/08/25 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
16/05/25 Nils Hansen proposed to acquire remaining 38.55% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?73 million. CI
14/05/25 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
17/04/25 H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025 CI
09/04/25 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2024 CI
27/03/25 H&R GmbH & Co. KGaA Says Postponement Of The Publication Of The Consolidated Financial Statements And The Annual Report 2024 RE
1 day-0.68%
Current month+8.82%
1 month+8.82%
3 months+48.89%
6 months+80.93%
Current year+72.49%
1 week 7.1
Extreme 7.1
7.46
1 month 6.76
Extreme 6.76
7.46
Current year 3.91
Extreme 3.91
7.46
1 year 3.91
Extreme 3.91
7.46
3 years 3.23
Extreme 3.23
7.46
5 years 3.23
Extreme 3.23
9.54
10 years 3.23
Extreme 3.23
18.88
Manager TitleAgeSince
Chief Executive Officer 61 01/01/2016
Investor Relations Contact - 01/01/2006
Director TitleAgeSince
Chairman 62 17/04/2012
Director/Board Member 71 01/05/2011
Director/Board Member 69 01/05/2011
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+49.19%+52.58% 312M
+0.84%+1.57%+0.44%+28.87% 218B
+1.18%+1.61%+6.28%+31.46% 122B
-1.98%-0.73%-6.40%+28.28% 79.75B
+0.83%-1.93%+3.19%+0.84% 62.17B
+3.44%+10.37%+545.20%+283.63% 61.47B
-0.73%-3.84%-25.41%-44.17% 37.07B
+1.83%-2.49%+4.49%-21.99% 31.56B
+0.22%-3.23%+30.20%+57.06% 24.29B
-0.51%-1.87%+2.56%-23.99% 24.14B
Average +0.44%+0.27%+60.97%+39.26% 66.08B
Weighted average by Cap. +0.68%+1.12%+51.56%+42.93%

Financials

2026 *2027 *
Net sales 1.4B 1.58B 1.32B 1.19B 2.25B 152B 2.28B 15.82B 6.09B 77.68B 5.95B 5.82B 249B 1.36B 1.55B 1.29B 1.17B 2.2B 148B 2.22B 15.44B 5.94B 75.83B 5.81B 5.68B 243B
Net income 48.09M 54.61M 45.56M 41.14M 77.53M 5.24B 78.53M 545M 210M 2.68B 205M 201M 8.58B 13.79M 15.66M 13.06M 11.79M 22.23M 1.5B 22.52M 156M 60.15M 768M 58.8M 57.51M 2.46B
Net Debt 22.87M 25.97M 21.67M 19.56M 36.87M 2.49B 37.34M 259M 99.76M 1.27B 97.51M 95.38M 4.08B 8.65M 9.82M 8.2M 7.4M 13.95M 942M 14.13M 98.06M 37.74M 482M 36.89M 36.08M 1.54B
Logo H&R GmbH & Co. KGaA
H&R GmbH & Co KGaA is a Germany-based manufacturing of chemical and pharmaceutical speciality products. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.
Employees
1,688
Date Price Change Volume
30/09/26 €7.400 0.00% 3,360
29/09/26 €7.400 +0.27% 3,650
28/09/26 €7.380 -0.54% 7,895
25/09/26 €7.420 -0.54% 3,430
24/09/26 €7.460 +0.81% 1,748
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
7.400EUR
Average target price
7.500EUR
Spread / Average Target
+1.35%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2HRA Stock